Characteristics of the patients (n (% of overall)) | CAP > 50 y.o. (149,555 (100%)) | P-CAP > 50 y.o. (8270 (5.53%)) | CAP 50–69 y.o. (37,807(25.3%)) | CAP 70–89 y.o. (85,159 (56.9%)) | CAP ≥ 90 y.o. (26,589 (17.8%)) |
---|---|---|---|---|---|
Male gender | 78,862 (52.7%) | 4794 (58.0%) | 23,510 (62.2%) | 45,753 (53.7%) | 9599 (36.1%) |
Age (years) | 78.1 (12.0) | 73.7 (12.4) | 60.9 (5.5) | 81.2 (5.4) | 92.9 (2.8) |
Alcohol | 12,614 (8.4%) | 1187 (14.4%) | 6,980 (18.5%) | 5234 (6.15%) | 400 (1.50%) |
Tobacco | 18,225 (12.2%) | 1912 (23.1%) | 10,151 (26.8%) | 7530 (8.84%) | 544 (2.05%) |
No comorbidity | 10,847 (7.3%) | 570 (6.89%) | 6,333 (16.8%) | 3620 (4.25%) | 894 (3.36%) |
HR comorbidities | 50,587 (33.8%) | 2962 (35.8%) | 14,137 (36.8%) | 29,732 (34.9%) | 6718 (25.3%) |
Solely HR comorbidities | 3349 (2.24%) | 201 (2.4%) | 1898 (5.02%) | 1301 (1.53%) | 150 (0.56%) |
No HR comorbidity | 98,968 (66.2%) | 5308 (64.2%) | 23,670 (62.6%) | 55,427 (65.1%) | 19,871 (74.7%) |
One HR comorbidity | 42,670 (28.5%) | 2423 (29.3%) | 11,432 (30.2%) | 25,203 (29.6%) | 6035 (22.7%) |
≥ 2 HR comorbidities | 7917 (5.29%) | 539 (6.5%) | 2705 (7.15%) | 4,529 (5.32%) | 683 (2.57%) |
Number of HR comorbidities | 0.40 (0.62) | 0.44 (0.66) | 0.47 (0.69) | 0.41 (0.62) | 0.28 (0.51) |
Solid tumor | 36,540 (24.4%) | 2042 (24.7%) | 9885 (26.2%) | 21,717 (25.5%) | 4938 (18.6%) |
Hematological malignancy | 10,693 (7.15%) | 705 (8.52%) | 2491 (6.59%) | 6736 (7.91%) | 1466 (5.51%) |
Auto-immune disorders | 6731 (4.50%) | 384 (4.64%) | 1860 (4.92%) | 4113 (4.83%) | 758 (2.85%) |
Primitive immune deficiency | 2392 (1.60%) | 187 (2.26%) | 957 (2.53%) | 1276 (1.50%) | 159 (0.60%) |
Organ transplant recipient | 2298 (1.54%) | 153 (1.85%) | 1567 (4.14%) | 654 (0.77%) | 77 (0.29%) |
HIV | 698 (0.47%) | 91 (1.10%) | 578 (1.53%) | 118 (0.14%) | 2 (0.01%) |
Asplenia—hyposplenia | 636 (0.43%) | 705 (8.52%) | 266 (0.70%) | 324 (0.38%) | 46 (0.17%) |
AR comorbidities | 135,359 (90.5%) | 7499 (90.7%) | 29,576 (78.2%) | 80,238 (94.2%) | 25,545 (96.1%) |
Solely AR comorbidities | 88,121 (58.9%) | 4738 (57.3%) | 17,337 (45.9%) | 51,807 (60.8%) | 18,977 (71.4%) |
No AR comorbidity | 14,196 (9.5%) | 771 (9.32%) | 8231 (21.8%) | 4921 (5.78%) | 1044 (3.93%) |
One AR comorbidity | 32,150 (21.5%) | 1819 (22.0%) | 10,547 (27.9%) | 16,646 (19.5%) | 4957 (18.6%) |
2 AR comorbidities | 41,724 (27.9%) | 2537 (30.7%) | 9295 (24.6%) | 24,531 (28.8%) | 7898 (29.7%) |
3 AR comorbidities | 33,826 (22.6%) | 1862 (22.5%) | 5802 (15.3%) | 20,976 (24.6%) | 7048 (26.5%) |
≥ 4 AR comorbidities | 27,659 (18.5%) | 1281 (15.5%) | 3932 (10.4%) | 18,085 (21.2%) | 5642 (21.2%) |
Number of AR comorbidities | 2.27 (1.39) | 2.19 (1.32) | 1.69 (1.36) | 2.45 (1.35) | 2.51 (1.28) |
Chronic cardiac diseases | 115,702 (77.4%) | 6118 (74.0%) | 21,630 (57%) | 70,749 (83.1%) | 23,323 (87.7%) |
Malnutrition | 52,338 (35.0%) | 2651 (32.1%) | 8819 (23.3%) | 30,732 (36.1%) | 12,787 (48.1%) |
Chronic respiratory diseases | 45,696 (30.6%) | 3782 (45.7%) | 12,710 (33.6%) | 27,124 (31.9%) | 5862 (22.1%) |
Diabetes mellitus | 35,250 (23.6%) | 1905 (23.0%) | 8067 (21.3%) | 22,917 (26.9%) | 4266 (16.0%) |
Neurodegenerative diseases | 30,027 (20.1%) | 848 (10.3%) | 1929 (5.10%) | 20,246 (23.8%) | 7852 (29.5%) |
Chronic kidney diseases | 28,074 (18.8%) | 1281 (15.5%) | 3832 (10.1%) | 17,271 (20.3%) | 6971 (26.2%) |
Stroke | 24,605 (16.5%) | 874 (10.6%) | 3367 (8.9%) | 16,187 (19.0%) | 5051 (19.0%) |
Chronic liver diseases | 7599 (5.08%) | 651 (7.87%) | 3466 (9.2%) | 3631 (4.26%) | 502 (1.89%) |
HR and AR comorbidities | |||||
≥ 1 HR and ≥ 1 AR | 47,238 (31.6%) | 2761 (33.4%) | 12,239 (32.4%) | 28,431 (33.4%) | 6568 (24.7%) |